Charlotte P. Chang

FDA investigator

Appears on 3 documents from 2022 to 2026, mostly at sites in New Jersey. Most often cites what specifications must you establish? (21 CFR 111.70).

3
Documents on file
14.0
Observations per 483
2022
First seen
2026
Most recent

What they cite most

From 42 observations

Activity by year

2022: 1, 2023: 1, 2026: 1

Where

New Jersey 3

Is Charlotte P. Chang coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

3 documents, newest first
FirmOpen
483 Neeyaan LLCJan 27, 2026 · Cranbury, New Jersey
483 Aspire Pharmaceuticals Inc.Jul 14, 2023 · Somerset, New Jersey
483 Aspire Pharmaceuticals Inc.Feb 3, 2022 · Somerset, New Jersey

About this profile

What does Charlotte P. Chang inspect?

Charlotte P. Chang appears on 3 documents on file covering 2 sites, mostly in New Jersey.

What do they cite most often?

21 CFR 111.70 (what specifications must you establish?), followed by 21 CFR 111.123 and 21 CFR 111.75.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Charlotte P. Chang is dated Jan 27, 2026.